{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:38:10Z","timestamp":1790523490408,"version":"4.1.0"},"reference-count":82,"publisher":"European Respiratory Society (ERS)","issue":"139","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2015,12,15]]},"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>Tuberculosis (TB) remains a global threat with more than 9 million new infections. Treatment remains difficult and there has been no change in the duration of the standard regimen since the early 1980s. Moreover, many patients are unable to tolerate this treatment and discontinue therapy, increasing the risk of resistance. There is a growing tide of multidrug resistance and few effective antibiotics to tackle the problem. Since the turn of the millennium there has been a surge in interest in developing new therapies for TB and a number of new drugs have been developed. In this review the repurposing of moxifloxacin, an 8-methoxy-fluoroquinolone, for TB treatment is discussed. The evidence that underpins the development of this agent is reviewed. The results of the recently completed phase III trials are summarised and the reasons for the unexpected outcome are explored. Finally, the design of new trials that incorporate moxifloxacin, and that address both susceptible disease and multidrug resistance, is described.<\/jats:p>","DOI":"10.1183\/16000617.0085-2015","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T20:57:47Z","timestamp":1456779467000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["The role of moxifloxacin in tuberculosis therapy"],"prefix":"10.1183","volume":"25","author":[{"given":"Stephen H.","family":"Gillespie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"2024102403194068000_25.139.19.1","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(81)90022-X"},{"key":"2024102403194068000_25.139.19.2","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946\u20131986, with relevant subsequent publications","volume":"3","author":"Fox","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102403194068000_25.139.19.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4001"},{"key":"2024102403194068000_25.139.19.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2012.02.033"},{"key":"2024102403194068000_25.139.19.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.339.6116.130"},{"key":"2024102403194068000_25.139.19.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112433"},{"key":"2024102403194068000_25.139.19.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62002-X"},{"key":"2024102403194068000_25.139.19.8","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.12549"},{"key":"2024102403194068000_25.139.19.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407426"},{"key":"2024102403194068000_25.139.19.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314210"},{"key":"2024102403194068000_25.139.19.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315817"},{"key":"2024102403194068000_25.139.19.12","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-353"},{"key":"2024102403194068000_25.139.19.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.09.013"},{"key":"2024102403194068000_25.139.19.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200140001-00001","article-title":"Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration","volume":"40","author":"Stass","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"2024102403194068000_25.139.19.15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"M\u00fcller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102403194068000_25.139.19.16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01036-07"},{"key":"2024102403194068000_25.139.19.17","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.43.11.2793","article-title":"Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone","volume":"43","author":"Sullivan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102403194068000_25.139.19.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2600-2603.2000"},{"key":"2024102403194068000_25.139.19.19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.835"},{"key":"2024102403194068000_25.139.19.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.3.393"},{"key":"2024102403194068000_25.139.19.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00287-09"},{"key":"2024102403194068000_25.139.19.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.suppl_1.85"},{"key":"2024102403194068000_25.139.19.23","doi-asserted-by":"publisher","DOI":"10.1159\/000093486"},{"key":"2024102403194068000_25.139.19.24","doi-asserted-by":"publisher","DOI":"10.1086\/521894"},{"key":"2024102403194068000_25.139.19.25","doi-asserted-by":"publisher","DOI":"10.1086\/424849"},{"key":"2024102403194068000_25.139.19.26","first-page":"577","article-title":"Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"372","author":"Gillespie","year":"2015","journal-title":"N Engl J Med"},{"key":"2024102403194068000_25.139.19.27","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/AAC.42.8.2066","article-title":"In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis","volume":"42","author":"Ji","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102403194068000_25.139.19.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200310-1380OC"},{"key":"2024102403194068000_25.139.19.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-885OC"},{"key":"2024102403194068000_25.139.19.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200305-682OC"},{"key":"2024102403194068000_25.139.19.31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.780-782.2004"},{"key":"2024102403194068000_25.139.19.32","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki376"},{"key":"2024102403194068000_25.139.19.33","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"Johnson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102403194068000_25.139.19.34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-360OC"},{"key":"2024102403194068000_25.139.19.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60333-0"},{"key":"2024102403194068000_25.139.19.36","first-page":"128","article-title":"A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102403194068000_25.139.19.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200901-0078OC"},{"key":"2024102403194068000_25.139.19.38","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(84)90165-7"},{"key":"2024102403194068000_25.139.19.39","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(86)90027-9"},{"key":"2024102403194068000_25.139.19.40","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"2024102403194068000_25.139.19.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(08)70039-8"},{"key":"2024102403194068000_25.139.19.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055191"},{"key":"2024102403194068000_25.139.19.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00239-X"},{"key":"2024102403194068000_25.139.19.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1666ST"},{"key":"2024102403194068000_25.139.19.45","first-page":"688","article-title":"Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia","volume":"49","author":"Marzuki","year":"2008","journal-title":"Singapore Med J"},{"key":"2024102403194068000_25.139.19.46","unstructured":"World Health Organization. Global Tuberculosis Report. Geneva, World Health Organization, 2015."},{"key":"2024102403194068000_25.139.19.47","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00309102"},{"key":"2024102403194068000_25.139.19.48","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.95.08081384"},{"key":"2024102403194068000_25.139.19.49","doi-asserted-by":"publisher","DOI":"10.1086\/598929"},{"key":"2024102403194068000_25.139.19.50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050176"},{"key":"2024102403194068000_25.139.19.51","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1367"},{"key":"2024102403194068000_25.139.19.52","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00105-15"},{"key":"2024102403194068000_25.139.19.53","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku415"},{"key":"2024102403194068000_25.139.19.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0661OC"},{"key":"2024102403194068000_25.139.19.55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050075"},{"key":"2024102403194068000_25.139.19.56","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv178"},{"key":"2024102403194068000_25.139.19.57","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ195"},{"key":"2024102403194068000_25.139.19.58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0272-5231(21)00072-1","article-title":"Bacteriologic basis of short-course chemotherapy for tuberculosis","volume":"1","author":"Grosset","year":"1980","journal-title":"Clin Chest Med"},{"key":"2024102403194068000_25.139.19.59","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00384-12"},{"key":"2024102403194068000_25.139.19.60","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3937"},{"key":"2024102403194068000_25.139.19.61","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect Immun"},{"key":"2024102403194068000_25.139.19.62","doi-asserted-by":"publisher","DOI":"10.1038\/35016103"},{"key":"2024102403194068000_25.139.19.63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006914"},{"key":"2024102403194068000_25.139.19.64","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70139-0"},{"key":"2024102403194068000_25.139.19.65","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00073611"},{"key":"2024102403194068000_25.139.19.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201964"},{"key":"2024102403194068000_25.139.19.67","doi-asserted-by":"publisher","DOI":"10.3201\/eid1602.090968"},{"key":"2024102403194068000_25.139.19.68","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki191"},{"key":"2024102403194068000_25.139.19.69","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir889"},{"key":"2024102403194068000_25.139.19.70","unstructured":"World Health Organization. Towards Universal Access to Diagnosis and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by 2015. Geneva, World Health Organization, 2014."},{"key":"2024102403194068000_25.139.19.71","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.13.122028"},{"key":"2024102403194068000_25.139.19.72","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201007-1126ED"},{"key":"2024102403194068000_25.139.19.73","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0077OC"},{"key":"2024102403194068000_25.139.19.74","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks389"},{"key":"2024102403194068000_25.139.19.75","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2289-2293.2005"},{"key":"2024102403194068000_25.139.19.76","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2294-2301.2005"},{"key":"2024102403194068000_25.139.19.77","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06125-11"},{"key":"2024102403194068000_25.139.19.78","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01354-09"},{"key":"2024102403194068000_25.139.19.79","first-page":"859","article-title":"Chimiotherapie de courte duree de la tuberculose. Essai cooperatif francais. [Short-term chemotherapy of tuberculosis. Cooperative French trial.]","volume":"11","author":"Pretet","year":"1983","journal-title":"Rev Fr Mal Respir"},{"key":"2024102403194068000_25.139.19.80","first-page":"239","article-title":"Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I","volume":"124","author":"Mehrotra","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"2024102403194068000_25.139.19.81","first-page":"165","article-title":"Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study","volume":"123","author":"East African\/British Medical Research Councils Study","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"2024102403194068000_25.139.19.82","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(81)90016-7"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0085-2015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T23:58:23Z","timestamp":1740355103000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0085-2015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":82,"journal-issue":{"issue":"139","published-online":{"date-parts":[[2016,2,29]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1183\/16000617.0085-2015"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0085-2015","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]}}}